Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.09
+0.32 (2.51%)
At close: Jul 2, 2025, 4:00 PM
13.00
-0.09 (-0.69%)
After-hours: Jul 2, 2025, 6:49 PM EDT

Korro Bio Statistics

Total Valuation

Korro Bio has a market cap or net worth of $122.92 million. The enterprise value is $29.11 million.

Market Cap 122.92M
Enterprise Value 29.11M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

Korro Bio has 9.39 million shares outstanding. The number of shares has increased by 167.19% in one year.

Current Share Class 9.39M
Shares Outstanding 9.39M
Shares Change (YoY) +167.19%
Shares Change (QoQ) +0.18%
Owned by Insiders (%) 6.41%
Owned by Institutions (%) 62.62%
Float 4.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 25.15
Forward PS 99.59
PB Ratio 0.88
P/TBV Ratio 0.88
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 6.04
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.41, with a Debt / Equity ratio of 0.33.

Current Ratio 9.41
Quick Ratio 9.07
Debt / Equity 0.33
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -60.22% and return on invested capital (ROIC) is -32.13%.

Return on Equity (ROE) -60.22%
Return on Assets (ROA) -29.82%
Return on Invested Capital (ROIC) -32.13%
Return on Capital Employed (ROCE) -50.43%
Revenue Per Employee $46,356
Profits Per Employee -$840,490
Employee Count 104
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

In the past 12 months, Korro Bio has paid $124,000 in taxes.

Income Tax 124,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -61.33% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -61.33%
50-Day Moving Average 14.44
200-Day Moving Average 32.12
Relative Strength Index (RSI) 49.12
Average Volume (20 Days) 123,676

Short Selling Information

The latest short interest is 925,793, so 9.86% of the outstanding shares have been sold short.

Short Interest 925,793
Short Previous Month 992,005
Short % of Shares Out 9.86%
Short % of Float 18.94%
Short Ratio (days to cover) 4.93

Income Statement

In the last 12 months, Korro Bio had revenue of $4.82 million and -$87.41 million in losses. Loss per share was -$9.44.

Revenue 4.82M
Gross Profit 4.82M
Operating Income -95.48M
Pretax Income -81.17M
Net Income -87.41M
EBITDA -91.41M
EBIT -95.48M
Loss Per Share -$9.44
Full Income Statement

Balance Sheet

The company has $114.95 million in cash and $45.19 million in debt, giving a net cash position of $93.81 million or $9.99 per share.

Cash & Cash Equivalents 114.95M
Total Debt 45.19M
Net Cash 93.81M
Net Cash Per Share $9.99
Equity (Book Value) 138.96M
Book Value Per Share 14.80
Working Capital 108.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$62.64 million and capital expenditures -$12.41 million, giving a free cash flow of -$75.05 million.

Operating Cash Flow -62.64M
Capital Expenditures -12.41M
Free Cash Flow -75.05M
FCF Per Share -$7.99
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -1,980.44%
Pretax Margin -1,810.56%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Korro Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -167.19%
Shareholder Yield -167.19%
Earnings Yield -71.11%
FCF Yield -61.05%

Analyst Forecast

The average price target for Korro Bio is $85.67, which is 554.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target $85.67
Price Target Difference 554.47%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 123.56%
EPS Growth Forecast (5Y) -6.23%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Korro Bio has an Altman Z-Score of 1 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1
Piotroski F-Score 1